Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5M Sell
34,637
-1,486
-4% -$509K 0.24% 101
2026
Q1
$12.7M Sell
36,123
-70
-0.2% -$25K 0.27% 84
2025
Q4
$11.8M Buy
36,193
+874
+2% +$277K 0.24% 91
2025
Q3
$9.97M Sell
35,319
-210
-0.6% -$60.9K 0.2% 109
2025
Q2
$9.92M Sell
35,529
-1,173
-3% -$332K 0.21% 102
2025
Q1
$11.4M Sell
36,702
-179
-0.5% -$52.9K 0.26% 83
2024
Q4
$9.61M Buy
36,881
+1,189
+3% +$353K 0.21% 101
2024
Q3
$11.5M Sell
35,692
-416
-1% -$136K 0.26% 80
2024
Q2
$11.3M Sell
36,108
-496
-1% -$146K 0.28% 73
2024
Q1
$10.4M Sell
36,604
-915
-2% -$268K 0.24% 82
2023
Q4
$10.8M Sell
37,519
-607
-2% -$165K 0.25% 76
2023
Q3
$10.2M Sell
38,126
-525
-1% -$131K 0.27% 72
2023
Q2
$8.58M Sell
38,651
-1,396
-3% -$324K 0.23% 88
2023
Q1
$9.68M Sell
40,047
-911
-2% -$224K 0.27% 72
2022
Q4
$10.8M Sell
40,958
-980
-2% -$263K 0.31% 59
2022
Q3
$9.45M Sell
41,938
-248
-0.6% -$60.1K 0.29% 68
2022
Q2
$10.3M Sell
42,186
-826
-2% -$202K 0.29% 71
2022
Q1
$10.4M Sell
43,012
-2,919
-6% -$671K 0.25% 86
2021
Q4
$10.3M Sell
45,931
-2,532
-5% -$534K 0.24% 96
2021
Q3
$10.3M Sell
48,463
-72,360
-60% -$16.7M 0.27% 88
2021
Q2
$29.4M Sell
120,823
-6,407
-5% -$1.58M 0.77% 24
2021
Q1
$31.7M Sell
127,230
-1,361
-1% -$325K 0.87% 18
2020
Q4
$29.6M Sell
128,591
-3,445
-3% -$794K 0.95% 15
2020
Q3
$33.6M Buy
132,036
+1,636
+1% +$405K 1.33% 8
2020
Q2
$30.8M Buy
130,400
+3,154
+2% +$720K 1.29% 9
2020
Q1
$25.8M Buy
127,246
+11,441
+10% +$2.5M 1.19% 8
2019
Q4
$27.9M Buy
115,805
+21,997
+23% +$4.85M 1.04% 14
2019
Q3
$18.2M Buy
+93,808
New +$18M 0.79% 26
2018
Q4
Sell
-23,003
Closed -$4.77M 630
2018
Q3
$4.77M Buy
23,003
+509
+2% +$100K 0.18% 163
2018
Q2
$4.15M Buy
22,494
+1,852
+9% +$328K 0.18% 172
2018
Q1
$3.52M Buy
+20,642
New +$3.79M 0.16% 180
2017
Q4
Sell
-14,856
Closed -$2.77M 639
2017
Q3
$2.77M Buy
14,856
+565
+4% +$100K 0.16% 172
2017
Q2
$2.46M Buy
14,291
+5,592
+64% +$910K 0.16% 175
2017
Q1
$1.43M Buy
8,699
+1,460
+20% +$243K 0.1% 249
2016
Q4
$1.06M Buy
7,239
+2,359
+48% +$355K 0.08% 278
2016
Q3
$814K Buy
4,880
+100
+2% +$16.9K 0.08% 250
2016
Q2
$727K Sell
4,780
-14
-0.3% -$2.18K 0.08% 263
2016
Q1
$719K Sell
4,794
-105
-2% -$15.6K 0.09% 250
2015
Q4
$795K Buy
4,899
+200
+4% +$31.4K 0.1% 224
2015
Q3
$650K Sell
4,699
-25
-0.5% -$3.94K 0.08% 264
2015
Q2
$725K Buy
+4,724
New +$757K 0.09% 269
2015
Q1
Sell
-4,724
Closed -$744K 255
2014
Q4
$752K Sell
4,724
-1,950
-29% -$304K 0.09% 257
2014
Q3
$937K Sell
6,674
-300
-4% -$39.2K 0.12% 209
2014
Q2
$826K Buy
6,974
+339
+5% +$39.2K 0.11% 224
2014
Q1
$818K Hold
6,635
0.12% 208
2013
Q4
$757K Buy
6,635
+275
+4% +$31.3K 0.11% 211
2013
Q3
$712K Hold
6,360
0.12% 194
2013
Q2
$627K Buy
+6,360
New +$660K 0.11% 206

Other funds holding AMGN

Ancora Advisors's AMGN Position: Q2 2026 in Review

Ancora Advisors reduced its Amgen (AMGN) stake by 4.1% in Q2 2026, selling an estimated $509K and leaving 34,637 shares worth $12.5M. The position accounts for 0.24% of the portfolio, ranked #101.

Ancora Advisors first reported a position in AMGN in Q2 2013 and has held it in 48 quarters since. The position peaked at $33.6M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ancora Advisors held 34,637 shares of Amgen worth $12.5M as of Q2 2026.
  • Ancora Advisors sold 1,486 Amgen shares in Q2 2026, an estimated $509K.
  • Amgen made up 0.24% of Ancora Advisors's portfolio in Q2 2026, its #101 holding.
  • Ancora Advisors first reported a position in Amgen in Q2 2013 and has held it in 48 quarters since.
  • Ancora Advisors's Amgen position peaked at $33.6M in Q3 2020.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.